You just read:

Janssen Submits U.S. & EU Regulatory Applications Seeking Approval of DARZALEX® (daratumumab) Split Dosing Regimen

News provided by

The Janssen Pharmaceutical Companies of Johnson & Johnson

Aug 08, 2018, 07:30 ET